Metraipolis › archive › dc_ff58e29f2de5

Tyrosine kinase inhibitors in Kosaki/Penttinen syndromes: new reports, follow-up of treated individuals and literature review — Europe PMC PMID:42420563

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42420563
DOI
10.1038/s41431-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-10-07T21:34:54.679Z
SHA-256 of the archived text
9827537bf0f37e95b8c105aaba8e1fa273230e9d57ba3733f731ffd2e89f7dfd
Stable URL of this page
https://metraipolis.com/documento/dc_ff58e29f2de5

How to cite

Tyrosine kinase inhibitors in Kosaki/Penttinen syndromes: new reports, follow-up of treated individuals and literature review — Europe PMC PMID:42420563 — Europe PMC (en), https://europepmc.org/article/MED/42420563 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff58e29f2de5 (Metraipolis archive dc_ff58e29f2de5, sha256 9827537bf0f37e95b8c105aaba8e1fa273230e9d57ba3733f731ffd2e89f7dfd)
BibTeX
@misc{dcff58e29f2de5,
  title = {Tyrosine kinase inhibitors in Kosaki/Penttinen syndromes: new reports, follow-up of treated individuals and literature review — Europe PMC PMID:42420563},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42420563},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff58e29f2de5; sha256 9827537bf0f37e95b8c105aaba8e1fa273230e9d57ba3733f731ffd2e89f7dfd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42420563. Agents can read the archived copy with the MCP tool read_document.